Skip to search formSkip to main contentSkip to account menu

Doxil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
PurposeOur recent studies show specific localization of long-circulating liposomes (LCL) within the endosomal/lysosomal… 
Highly Cited
2007
Highly Cited
2007
Liposomes, modified with monoclonal antibodies, are suitable carriers for targeted delivery of chemotherapeutic drugs into brain… 
2005
2005
Objective: A phase I/II study of Doxil® combined with whole abdomen hyperthermia was conducted in patients with refractory… 
Highly Cited
2004
Highly Cited
2004
The application of tumor necrosis factor‐α (TNF) for the treatment of solid tumors is limited by its severe, life‐threatening… 
Highly Cited
2002
Highly Cited
2002
The stability and biological behavior of an in vitro system of doxorubicin (DXR) entrapped in NK911, polymer micelles, was… 
2002
2002
Pegylated-liposomal doxorubicin (Doxil™) is a form of liposomal doxorubicin in which the liposomes are coated with methoxypoly… 
Highly Cited
2000
Highly Cited
2000
It has previously been demonstrated in the setting of an isolated limb perfusion that application of high‐dose TNF‐α in… 
2000
2000
New therapies are needed for patients with advanced ovarian cancer who relapse after initial treatment with platinum and/or… 
2000
2000
Twenty-four patients with pleural mesotheliomareceived 50 mg/m2 of Doxil® every four weeks.At follow-up, the disease had…